Pharma Industry
Pharma Industry 06/10/2011
Theratechnologies identifies second generation GRF peptide and initiates pre-clinical studies
The new peptide may be suitable for the treatment of a broader range of medical indications and methods of administration than tesamorelin.
Pharma Industry 05/10/2011
Clinical trials for abandoned products should go public, scientists insist
Clinical trial sponsors have an ethical responsibility to study participants, science and society to disclose research results, even when product development is subsequently abandoned.
Pharma Industry 01/10/2011
PatientView announces the release of its latest report
'What pharma companies do patient groups think are best at HIV/AIDS R&D?'
Pharma Industry 28/09/2011
Generics "save the US $3B every week"
Use of generic prescription drugs saved the US $158 billion last year, or $3 billion every week.
Pharma Industry 28/09/2011
India may cap foreign investment in pharma
India makes more than 20 percent of the world’s generics and its industry is expected to grow from $19 billion in sales in 2009 to $50 billion by 2020.
Pharma Industry 26/09/2011
The Nation examines rise in unregulated drug trials in South America
40 to 65 percent of clinical trials on FDA-regulated products in 2008 took place overseas.
Pharma Industry 26/09/2011
CytoDyn files provisional patent application for humanized version of Cytolin to treat HIV
Cytolin is a monoclonal antibody for the treatment of HIV infection.
Pharma Industry 21/09/2011
Regulatory update – Celsentri/Selzentry® (maraviroc)
Viiv Healthcare withdrew its applications to US and European regulators for the once-daily HIV drug Celsentri/Selzentry® (maraviroc).
Pharma Industry 20/09/2011
Industry gives pledge on affordable drugs
The pharmaceutical industry has pledged to help tackle poor drug distribution and other factors limiting affordable access to medicines for chronic diseases in the developing world, while attempting to steer discussion away from high prices imposed by patents.
Pharma Industry 20/09/2011
Stephen Colbert on faux innovation by pharma companies to extend patents
An interesting video that explains evergreening of patents by pharmaceutical companies in a very funny way.
Pharma Industry 17/09/2011
Teva announces drug development investment in Cocrystal Discovery Inc. for novel antiviral therapeutics
The Company will develop for Teva an antiviral drug targeting the polymerase enzyme of the hepatitis C virus.
Pharma Industry 12/09/2011
Drug delivery device sales "will hit $197B in 2014"
Worldwide sales of advanced drug delivery systems - such as inhalers, injections and infusion pumps - will grow from a value of $139 billion in 2009 to $197 billion in 2014, says a new report.
Pharma Industry 10/09/2011
Lofty hopes confront Gilead's 4-drug HIV pill
Key trial results expected this month; May need to show superiority to rivals to boost stock; Sales forecasts vary widely.
Pharma Industry 07/09/2011
Offshore manufacturing poses more risk: study
Is making pharmaceuticals offshore more problematic than in the US? A new study suggests the answer is resoundingly ‘yes.’
Pharma Industry 07/09/2011
Theratechnologies enters new phase of drug testing
Lucrative market; Company believes product has wider uses.
Pharma Industry 07/09/2011
EFPIA backs move towards full clinical data transparency
In future, virtually all data from the relevant clinical trials should be disclosed once a new medicine is cleared for marketing, believes the European Federation of Pharmaceutical Industries and Associations (EFPIA).
Pharma Industry 04/09/2011
Authorized generics are a double whammy: FTC
In an effort to thwart generic competition, brand-name drugmakers are promising not to launch so-called authorized generics if their generic rivals promise not to market copycat versions of the brand-name drugs, according to a new report from the US Federal Trade Commission.
Pharma Industry 01/09/2011
Clinical development to drive biomarkers market growth
Clinical development should emerge as the fastest-growing segment of a global biomarkers market expected to reach US$34 billion by 2017, a new report predicts.
Pharma Industry 27/08/2011
'Explosive' growth in foreign drug testing raises ethical questions
Pharmaceutical companies have been shifting research overseas for years and the number of foreign trials has skyrocketed.
More...
